Received Dec 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | UNK | 946915 | IM / LA |
Two to three days after receiving the hepatitis B vaccine, I developed persistent tinnitus (ringing in the ears). I did not have tinnitus prior to vaccination. The tinnitus has been continuous since onset and has not resolved. While driving for approximately 30?40 minutes, the ringing significantly worsens and is accompanied by a fear of losing consciousness. Medical evaluation is pending at the time of this report..
None
None
None
None
Medical evaluation pending at the time of this report.